A Survey on Illegal and Counterfeit Medicines for the Treatment of Erectile Dysfunctions in Italy

Journal of Sexual Medicine

Volumn 9, Issue 8, 2012, Pages 2130-2137

  Gaudiano, Maria Cristina ^a   Manna, Livia ^a   Rodomonte, Andrea Luca ^a   Bartolomei, Monica ^a   Bertocchi, Paola ^a   Gallinella, Bruno ^a   Antoniella, Eleonora ^a   Muleri, Nadia ^b   Civitelli, Gabriele ^a   Alimonti, Stefano ^a   Romanini, Laura ^a   Rufini, Leandro ^a   Valvo, Luisa ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Counterfeit; Illegal Medicine; PDE5 Inhibitors

Indexed keywords

COUNTERFEIT DRUG; EXCIPIENT; ILLICIT DRUG; PHOSPHODIESTERASE V INHIBITOR; SILDENAFIL; TADALAFIL; VARDENAFIL;

ARTICLE; AWARENESS; BLISTER PACK; DRUG FORMULATION; DRUG LABELING; DRUG MANUFACTURE; DRUG PACKAGING; DRUG SCREENING; ERECTILE DYSFUNCTION; EXPIRATION DATE; GENERAL PRACTITIONER; HEALTH HAZARD; HUMAN; ITALY; KNOWLEDGE; MEDICAL INFORMATION; MEDICAL SPECIALIST; ONLINE SYSTEM; PHARMACY; POLICE; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REPRODUCTIVE HEALTH;

EID: 84864505309     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2012.02770.x     Document Type: Article

References (39)

1. Department of Essential Drugs and Other Medicines. Guidelines for the development of measures to combat counterfeit drugs. (WHO/EDM/QSM/99.1.). WHO: Geneva. 1999. Available at: (accessed October 14, 2011).
2. World Health Organization. Substandard and counterfeit medicines (fact sheet no. 275). WHO: Geneva. 2003. Available at: (accessed October 14, 2011).
3. Ahmad K. Antidepressants are sold as antiretrovirals in DR Congo. Lancet 2004;363:713.
4. Dondorp AM, Newton PN, Mayxay M, Van Damme W, Smithuis FM, Yeung S, Petit A, Lynam AJ, Johnson A, Hien TT, McGready R, Farrar JJ, Looareesuwan S, Day NPJ, Green MD, White NJ. Fake antimalarials in Southeast Asia are a major impediment to malaria control: Multinational cross-sectional survey on the prevalence of fake antimalarials. Trop Med Int Health 2004;9:1241-6.
5. Rozendaal J. Fake antimalarial drugs in Cambodia. Lancet 2001;357:890.
6. Newton PN, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, Kesinee Chotivanich K, Mayxay M, Looareesuwan S, Farrar J, Nosten F, White NJ. Fake artesunate in Southeast Asia. Lancet 2001;357:1948-50.
7. McGinnis M. Media reports on medicine quality: Focusing on USAID-assisted countries by the promoting the quality of medicines program. Rockville, MD: United States Pharmacopeia; 2010.
8. Shakoor O, Taylor RB, Behrens RH. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health 1997;2:839-45.
9. Capell K, Timmons S, Wheatley J, Dawley H. What's in that pill? In Latin America, fake drugs are as lucrative as cocaine. Business Week Online. June 2001. Available at: (accessed October 14, 2011).
10. Laserson KF, Kenyon AS, Kenyon TA, Layloff T, Binkin NJ. Substandard tuberculosis drugs on the global market and their simple detection. Int J Tuberc Lung Dis 2001;5:448-54.
11. Newton PN, White NJ, Rozendaal JA, Green MD. Murder by fake drugs. BMJ 2002;324:800-1.
12. Rudolf PMM, Bernstein IBG. Counterfeit drugs. N Engl J Med 2004;350:1384-6.
13. O'Brien KL, Selanikio JD, Hecdivert C, Placide MF, Louis M, Barr K, Barr JR, Hospedales CJ, Lewis MJ, Schwartz B, Philen RM, St. Victor S, Espindola J, Needham LL, Denerville K. Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. JAMA 1998;279:1175-80.
14. Faivelson S. Counterfeit drugs slip into the U.S. market. Pharmacy Practice News. June 2002:7.
15. Juillet Y, Vlasto AP. Counterfeiting of medicinal drugs: Issues and threats. Fundam Clin Pharmacol 2005;19:621-4.
16. Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: Why industry and governments must communicate the dangers. PLoS Med 2005;2:302-8. Available at: (accessed October 14, 2011).
17. Newton PN, Green MD, Fernández FM, Day NPJ, White NJ. Counterfeit anti-infective drugs. Lancet Infect Dis 2006;6:602-13.
18. Kelesidis T, Kelesidis I, Rafailidis PI, Falagas ME. Counterfeit or substandard antimicrobial drugs: A review of the scientific evidence. J Antimicrob Chemother 2007;60:214-36.
19. U.S. Department of Health and Human Services. Buying medicines over the Internet. United States Pharmacopeia: Rockville. 2011. Available at: (accessed October 14, 2011).
20. WHO. General information on counterfeit medicines. WHO: Geneva 2011. Available at: (accessed October 14, 2011).
21. Food and Drug Administration-U.S. Department of Health & Human Services. Counterfeit medicine. 2012. Available at: (accessed October 14, 2011).
22. Council of Europe. Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health. 2011. Available at: (accessed October 14, 2011).
23. EDQM. Minimising the public health risks posed by counterfeit medical products and similar crimes. 2011. Available at: (accessed October 14, 2011).
24. IMPACT. The handbook. Facts | Activities | Documents developed by the Assembly and the Working Groups 2006-2010. Editors: IMPACT Secretariat at AIFA: Rome 2011. Available at: (accessed October 14, 2011).
25. Dorsey PJ, Hellstrom WJ. The illicit sale of medications for the treatment of erectile dysfunction: PDE-5 inhibitors: A prime target for counterfeiters. Medscape Today 2007. Available at: (accessed October 14, 2011).
26. Armstrong K, Schwartz JS, Asch DA. Direct sale of sildenafil (Viagra) to consumers over the Internet. N Engl J Med 1999;341:1389-92.
27. Jackson G, Arver S, Banks I, Stecher VJ. Counterfeit phosphodiesterase type 5 inhibitors pose significant safety risks. Int J Clin Pract 2010;64:497-504.
28. Counterfeit Medicines. Facts and practical advice. Coordinating Author D. Di Giorgio. AIFA/EDQM: Milano 2011.
29. Schnetzler G, Banks I, Kirby M, Zou KH, Symonds T. Characteristics, behaviors, and attitudes of men bypassing the healthcare system when obtaining phosphodiesterase type 5 inhibitors. J Sex Med 2010;7:1237-46.
30. Megget K. The "Global Disaster" of fake Internet pharmacies. 2007. Available at: (accessed October 14, 2011).
31. Hellstrom WJ. The growing concerns regarding counterfeit medications. J Sex Med 2011;8:1-3. Available at: (accessed October 14, 2011).
32. Vanderdonck F. Counterfeit medicines: A threat to public health and safety. Louv Med 2007;126:S138-42.
33. Counterfeit Medicines. Facts and case studies. Coordinating Author D. Di Giorgio. EDQM: Strasbourg 2009.
34. IMPACT Italia. IMPACT Italia. La task-force nazionale contro la contraffazione farmaceutica. 2010. Available at: (accessed October 14, 2011).
35. Wang PG, Wertheimer AI. Counterfeit medicines volume II: Detection, identification and analysis. 2012, in press.
36. Rodomonte AL, Gaudiano MC, Antoniella E, Lucente D, Crusco V, Bartolomei M, Bertocchi P, Manna L, Valvo L, Alhaique F, Muleri N. Counterfeit drugs detection by measurement of tablets and secondary packaging colour. J Pharm Biomed Anal 2010;53:215-20.
37. World Health Organization. The international pharmacopoeia. 4th edition. Geneva: WHO; 2008.
38. European Medicines Agency. Viagra: EPAR-Product information. 2010. Available at: (accessed October 14, 2011).
39. Gaudiano MC, Di Maggio A, Cocchieri E, Antoniella E, Bertocchi P, Alimonti S, Valvo L. Medicines informal market in Congo, Burundi and Angola: Counterfeit and sub-standard antimalarials. Malar J 2007;6:1-9. Available at: (accessed October 14, 2011).